@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_head { this: np:hasAssertion dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_assertion; np:hasProvenance dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_provenance; np:hasPublicationInfo dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_publicationInfo; a np:Nanopublication . dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_assertion a np:Assertion . dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_provenance a np:Provenance . dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_publicationInfo a np:PublicationInfo . } dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_assertion { miriam-gene:8493 a ncit:C16612 . lld:C1140680 a ncit:C7057 . dgn-gda:DGN8eb2bdb8fdbab4860510136fffa270db sio:SIO_000628 miriam-gene:8493, lld:C1140680; a sio:SIO_001121 . } dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_provenance { dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_assertion dcterms:description "[To illustrate the role of PPM1D in gynecological cancer cell chemoresistance and its regulation by Akt we have demonstrated that: (a) CDDP induced PPM1D down-regulation through proteasomal degradation in sensitive CECA cells; (b) CDDP induced PPM1D nuclear localization in resistant CECA cells, and nuclear exclusion in sensitive CECA cells and OVCA xenografts; (c) Over-expression of active Akt in sensitive CECA cells stabilized PPM1D content through inhibition of CDDP-induced PPM1D down-regulation; (d) Inhibition of Akt activity in resistant OVCA cells leads to decreased PPM1D stability and CDDP-induced down-regulation in resistant CECA cells; and (e) PPM1D is highly expressed in human ovarian tumor subtypes and in a tissue microarray panel of human ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:25154814; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP1213618.RAz-ovErmLOS1oQg59tc-51amtUYOAGO7Ovlp-hXbO58c130_publicationInfo { this: dcterms:created "2016-05-13T12:50:56+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }